Table 2

Medications used

MedicationAllFemale (n=114)Male (n=83)p Value (female vs male)
NSAID before baseline115 (58.4%)67 (58.8%)48 (57.8%)0.723
NSAID after baseline138 (70.6%)79 (69.3%)60 (72.3%)0.620
NSAID at 5-year follow-up90 (41.6%)52 (45.6%)30 (36.1%)0.199
Never DMARD73 (37.1%)45 (39.5%)28 (33.7%)0.411
MTX ever107 (54.3%)60 (51.6%)47 (65.6%)0.579
MTX alone or in combination with biological agent over ≥3 years and ongoing at 5-year follow-up53 (27%)30 (26.3%)23 (27.8%)0.916
Biological agent (started any time before 5-year visit)16 (8.1%)10 (8.8%)6 (7.2%)0.696
Sulfasalazine ever24 (12.2%)9 (9.7%)15 (18.1%)0.031
  • DMARD, disease-modifying antirheumatic drug; MTX, methotrexate; NSAID, non-steroidal anti-inflammatory drug.